Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT01738269

NCT01738269
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • There is enough relevant medical information available about the patient
  • The sample provided looks normal in appearance
  • There is at least 0.5 ml (a very small amount) of the sample available to use

Who may not be able to join:

  • The patient is under 18 years of age
  • There is not enough of the sample available to test
  • There is not enough medical information available about the patient
  • The sample has been frozen and thawed more than 3 times
  • The sample was stored or transported at above freezing temperatures (confirm with trial site)
  • The sample shows signs of being discoloured due to jaundice, high fat content, broken-down red blood cells, or contains visible particles (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Chinese PLA General Hospital
Registry
clinicaltrials_gov
Start date
1 November 2012
Est. completion
1 May 2013

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Establish reference in Chinese population

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov